Session Details
[S09]Advances of Structural Biology and its Application to Drug Development
Thu. Mar 27, 2025 1:15 PM - 2:45 PM JST
Thu. Mar 27, 2025 4:15 AM - 5:45 AM UTC
Thu. Mar 27, 2025 4:15 AM - 5:45 AM UTC
Room 9 (Fukuoka International Congress Center: 411 [4F])
Organizer: Koh Takeuchi (Grad. Sch. Pharm. Sci., The Univ. of Tokyo), Umeharu Ohto (Grad. Sch. Pharm. Sci., The Univ. of Tokyo)
Structural biology, which aims to understand biological phenomena based on the three-dimensional structure of biological macromolecules, has made substantial progress through advances in X-ray crystallography, nuclear magnetic resonance, and cryo-electron microscopy, as well as the integration of these techniques with computational techniques. The technical barrier in applying structural analysis to biological macromolecules has been reduced, and structural information has been utilized in broad areas of life science. In addition, the relationship between protein dynamics and function has also been established. There is an increasing demand for high-order structural information in various aspects of drug discovery. The structural analysis of macromolecules potentially leads to the discovery and development of drugs with novel mechanisms of action. This symposium aims to create an opportunity for five leading researchers in the structural biology field to share state-of-the-art techniques with the audience, thereby further promoting the development of structural biology and structure-guided drug discovery.
[S09-1]Structural basis of polyspecific drug interactions in SLC transporters
○Yongchan Lee1 (1. Grad. Sch. Med. Life Sci., Yokohama City Univ.)
[S09-2]Molecular and structural basis of oxalate uptake by an oxalate-degrading bacterium in the gut microbiota
○Atsuko Yamashita1 (1. IPR, Osaka Univ.)
[S09-3]An interaction mediated by a deprotonated lysine sidechain revealed by NMR
○Masaki Mishima1 (1. Tokyo Univ. Pharm. & Life Sci., Dep. Pharm)
[S09-4]Deciphering the Multi-state Conformational Equilibrium of HDM2 in the Regulation of p53 Binding
Kazuki Watanabe1, Qingci Zhao1, Ryosuke Iwatsuki1, Ryota Fukui1, Weitong Ren2, Yuji Sugita2, ○Noritaka Nishida1 (1. Chiba Univ, 2. RIKEN)
[S09-5]Structure of the high-affinity IgE receptor mediating type I hypersensitivity
○Umeharu Ohto1 (1. Grad. Sch. Pharm. Sci., The Univ. of Tokyo)